Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCohort Regulatory News (CHRT)

Share Price Information for Cohort (CHRT)

Share Price is delayed by 15 minutes
Get Live Data
1,256.00    -24.00 (-1.88%)
Bid:
1,246.00
Ask:
1,258.00
Spread: 12.00 (0.963%)
Market Cap: £575.57m
CHRT Live PriceLast checked at - London Stock Exchange

Intraday Cohort Share Chart

Contract Announcement

1 Aug 2017 07:00

RNS Number : 6448M
Cohort PLC
01 August 2017
 

1 August 2017

 

Cohort plc

("Cohort")

 

Contract Announcement

 

Cohort's EID and SEA awarded new contracts

 

Cohort, the independent technology group, is pleased to announce that its subsidiary EID has been awarded a contract by the Portuguese Navy for the supply of Integrated Communications systems to the Tejo Class Coastal Patrol Vessels, worth a total of €4.6 million.

The contract encompasses the supply of radio equipment, ICCS, integration engineering and logistic services. The contract also includes additional supplies for the second batch of the Viana do Castelo Oceanic Patrol Vessels, currently being built in Portugal.

 

Further to this, SEA has been awarded a contract by Hyundai Heavy Industries (HHI), which is in excess of £5m, for the supply of Torpedo Launcher Systems for the Southeast Asian market. These will be fitted to new ships that HHI are currently building.

 

The SEA system is based on the product in service with the UK Royal Navy and is currently being supplied to the Navies of Malaysia and Thailand. The system is unique in that it can be configured to fire any NATO standard light weight torpedo enabling SEA's customers to choose the best weapon independently and to potentially switch during the life of the ship.

 

Andy Thomis, Chief Executive of Cohort, said:

"These are both important orders for the Group. For SEA, the order is a demonstration of the international competitiveness of its torpedo launch system and its growing position as a supplier of naval systems to the important Southeast Asian region. For EID this is an affirmation of its importance to, and close relationship with, the Portuguese armed forces. Together they contribute to improved visibility of revenue in the current financial year and beyond.

 

"These contract awards, together with other recent wins, enhance the visibility of future Group revenue".

 

 

Ends

 

 

 

For further information, please contact:

 

 

Cohort plc

0118 909 0390

Andy Thomis, Chief Executive

 

Simon Walther, Finance Director

 

 

 

Investec Bank Plc

020 7597 5970

Keith Anderson / Daniel Adams

 

 

 

MHP Communications

020 3128 8100

Reg Hoare / Ollie Hoare

 

 

 

NOTES TO EDITORS

Cohort is the parent company of four innovative, agile and responsive businesses based in the UK and Portugal, providing a wide range of services and products for domestic and export customers in defence and related markets.

 

MASS is a specialist defence and technology business, focused on electronic warfare, information systems and cyber security.

www.mass.co.uk

 

MCL is an expert in the sourcing, design, integration and support of communications and surveillance technology for the defence and security markets.

www.marlboroughcomms.com

 

SEA is an advanced electronic systems and software house operating in the defence, transport and offshore energy markets.

www.sea.co.uk

 

EID designs and manufactures advanced communications systems for the defence and security markets.

www.eid.pt

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
CNTUASVRBBABOAR
Date   Source Headline
1st Jun 202611:41 amRNSTotal Voting Rights
27th May 20267:00 amRNSFull Year Trading Update
26th May 20267:00 amRNSNotice of Full Year Trading Update
12th May 202610:46 amRNSHolding(s) in Company
1st May 20269:37 amRNSTotal Voting Rights
10th Apr 20263:58 pmRNSDirector/PDMR Shareholding
10th Apr 202612:35 pmRNSHolding(s) in Company
2nd Apr 20267:00 amRNSBlock Listing Six Monthly Return
1st Apr 202610:10 amRNSTotal Voting Rights
26th Mar 20267:00 amRNSContract Announcement
23rd Mar 20267:00 amRNSContract Announcement
2nd Mar 202611:57 amRNSTotal Voting Rights
25th Feb 20269:51 amRNSBlock Listing Six Monthly Return
20th Feb 20267:00 amRNSDirector/PDMR Shareholding
17th Feb 20263:41 pmRNSHolding(s) in Company
16th Feb 20267:00 amRNSDirector/PDMR Shareholding
4th Feb 20269:35 amRNSHolding(s) in Company
2nd Feb 20264:54 pmRNSTotal Voting Rights
30th Jan 20267:00 amRNSContract Wins
20th Jan 202612:40 pmRNSHolding(s) in Company
15th Jan 20267:00 amRNSInterim Report 2025
5th Jan 20269:00 amRNS-RInvestor Presentation via Equity Development
2nd Jan 202612:40 pmRNSTotal Voting Rights
22nd Dec 20259:00 amRNS-RInvestor Presentation via Engage Investor
22nd Dec 20259:00 amRNS-RInvestor Presentation via Engage Investor
15th Dec 202511:56 amRNSDirector/PDMR Shareholding
11th Dec 20257:00 amRNSDirector/PDMR Shareholding
10th Dec 20257:01 amRNSHalf Year Results
1st Dec 202512:20 pmRNSTotal Voting Rights
28th Nov 20257:00 amRNSNotice of Half Year Results
4th Nov 202511:59 amRNSTotal Voting Rights
27th Oct 20254:37 pmRNSDirector/PDMR Shareholding
16th Oct 202510:11 amRNSDirector/PDMR Shareholding
7th Oct 20253:15 pmRNSDirector/PDMR Shareholding
7th Oct 20257:00 amRNSMASS secures £15.7m countermeasures contract
2nd Oct 202511:03 amRNSBlock Listing Six Monthly Return
1st Oct 20259:53 amRNSTotal Voting Rights
25th Sep 20254:59 pmRNSResult of AGM
25th Sep 20257:00 amRNSAGM Statement
19th Sep 20255:12 pmRNSDirector/PDMR Shareholding
12th Sep 20257:00 amRNS-RInvestor Presentation
10th Sep 20253:21 pmRNSDirector/PDMR Shareholding
3rd Sep 202510:57 amRNSDirector/PDMR Shareholding
1st Sep 202511:05 amRNSTotal Voting Rights
26th Aug 20253:22 pmRNSBlock Listing Six Monthly Return
20th Aug 20253:56 pmRNSAnnual Report and Notice of Annual General Meeting
15th Aug 20253:35 pmRNSDirector/PDMR Shareholding
11th Aug 20255:10 pmRNSDirector/PDMR Shareholding
1st Aug 20254:16 pmRNSTotal Voting Rights
17th Jul 20259:49 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.